153 related articles for article (PubMed ID: 7505192)
1. Re-evaluation of the need for pelvic lymphadenectomy in low grade prostate cancer.
Fournier GR; Narayan P
Br J Urol; 1993 Oct; 72(4):484-8. PubMed ID: 7505192
[TBL] [Abstract][Full Text] [Related]
2. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer.
Narayan P; Fournier G; Gajendran V; Leidich R; Lo R; Wolf JS; Jacob G; Nicolaisen G; Palmer K; Freiha F
Urology; 1994 Oct; 44(4):519-24. PubMed ID: 7524237
[TBL] [Abstract][Full Text] [Related]
3. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
4. Eliminating the need for per-operative frozen section analysis of pelvic lymph nodes during radical prostatectomy.
Bangma CH; Hop WC; Schröder FH
Br J Urol; 1995 Nov; 76(5):595-9. PubMed ID: 8535678
[TBL] [Abstract][Full Text] [Related]
5. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
[TBL] [Abstract][Full Text] [Related]
6. The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer.
Rogers E; Gürpinar T; Dillioglugil O; Kattan MW; Goad JR; Scardino PT; Griffith DP
Br J Urol; 1996 Sep; 78(3):419-25. PubMed ID: 8881954
[TBL] [Abstract][Full Text] [Related]
7. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
8. Predicting pelvic lymph node involvement in current-era prostate cancer.
Rahman S; Cosmatos H; Dave G; Williams S; Tome M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):906-10. PubMed ID: 21300478
[TBL] [Abstract][Full Text] [Related]
9. The staging pelvic lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer.
Alagiri M; Colton MD; Seidmon EJ; Greenberg RE; Hanno PM
Br J Urol; 1997 Aug; 80(2):243-6. PubMed ID: 9284196
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
Wyler SF; Sulser T; Seifert HH; Ruszat R; Forster TH; Gasser TC; Bachmann A
Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
[TBL] [Abstract][Full Text] [Related]
11. Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer.
Kava BR; Dalbagni G; Conlon KC; Russo P
Ann Surg Oncol; 1998 Mar; 5(2):173-80. PubMed ID: 9527271
[TBL] [Abstract][Full Text] [Related]
12. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection.
Burkhard FC; Bader P; Schneider E; Markwalder R; Studer UE
Eur Urol; 2002 Aug; 42(2):84-90; discussion 90-2. PubMed ID: 12160577
[TBL] [Abstract][Full Text] [Related]
13. [Radical perineal prostatectomy without lymphadenectomy. Patients with cT1 + 2, G1 +2, PSA < or = 10 ng/ml prostate carcinoma].
Jakse G; Brehmer B; Wolff JM; Aretz R; Handt S
Urologe A; 1999 Mar; 38(2):143-9. PubMed ID: 10231935
[TBL] [Abstract][Full Text] [Related]
14. [Indications for pelvic lymphadenectomy in clinically localized prostate cancer].
Peneau M; Villers A; Molinié V; Theis D; Soulié M
Prog Urol; 2004 Jun; 14(3):287-94. PubMed ID: 15373168
[TBL] [Abstract][Full Text] [Related]
15. Indications for pelvic lymphadenectomy in prostate cancer.
Link RE; Morton RA
Urol Clin North Am; 2001 Aug; 28(3):491-8. PubMed ID: 11590808
[TBL] [Abstract][Full Text] [Related]
16. Extended pelvic lymphadenectomy in patients with clinically localised prostate cancer: A prospective observational study.
Ramos JG; Caicedo JI; Cataño JG; Villarraga LG; Trujillo CG; Robledo D; Plata M
Actas Urol Esp; 2016 Sep; 40(7):446-52. PubMed ID: 26995770
[TBL] [Abstract][Full Text] [Related]
17. Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
Schumacher MC; Burkhard FC; Thalmann GN; Fleischmann A; Studer UE
Eur Urol; 2006 Aug; 50(2):272-9. PubMed ID: 16632187
[TBL] [Abstract][Full Text] [Related]
18. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
19. [Incidence of pelvic lymph node metastasis in radical prostatectomy].
Jeremić N; Cerović S; Brajusković G; Tomović S; Maletić-Vuković V
Vojnosanit Pregl; 2006 Dec; 63(12):1011-4. PubMed ID: 17252705
[TBL] [Abstract][Full Text] [Related]
20. Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection.
Brembilla G; Dell'Oglio P; Stabile A; Ambrosi A; Cristel G; Brunetti L; Damascelli A; Freschi M; Esposito A; Briganti A; Montorsi F; Del Maschio A; De Cobelli F
Eur Radiol; 2018 May; 28(5):1969-1976. PubMed ID: 29270644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]